Article: Activists give hedge fund a taste of its own medicine

MOST hedge fund managers are all too familiar with the idea of applying pressure on the management of underperforming companies. But Cheyne Capital, one of London's most pre-eminent hedge fund managers, is about to find itself on the wrong end of the argument.

In an ironic twist of events, a group of traditional institutional shareholders led by Scottish Widows Investment Partnership, are plotting a rebellion over the performance of Queen's Walk Investment - the Aim-listed investment vehicle that Cheyne brought to market 15 months ago.

Queen's Walk has been hammered by the fall-out from the collapse of "sub-prime'' lending in the US, issuing two profit warnings this year. Although the fund ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!